David H Brandwein

age ~67

from Saint Paul, MN

Get Report

Also known as:

Connected to:

David Brandwein Phones & Addresses

Psoriasis Patch
view source
US Patent:

20030077316, Apr 24, 2003
Filed:

Apr 2, 2001
Appl. No.:

09/824533
Inventors:

Jane Nichols - Bloomington MN, US
Teri Buseman - Minnetonka MN, US
David Rolf - Eden Prairie MN, US
David Brandwein - New Brighton MN, US
Daniel McWhorter - Eagan MN, US
International Classification:

A61K031/56
A61K031/60
A61L015/16
US Classification:

424/447000, 514/171000, 514/159000
Abstract:

The present invention provides a water insoluble, protective, adhesive skin patch useful for treating or preventing psoriasis, dermatitis, and/or eczema. The adhesive patch includes a backing that is treated with a sizing agent (e.g., a fluorocarbon solution, a silicone-containing compound, or a combination thereof). The present invention also provides a method for treating or preventing at least one of psoriasis, dermatitis, and eczema in a mammal (e.g., human) and a method for exfoliating the skin surface of a mammal.

Transdermal Administration Of N-(2,5-Disubstituted Phenyl)-N'-(3-Substituted Phenyl)-N'-Methyl Guanidines
view source
US Patent:

20030198662, Oct 23, 2003
Filed:

Apr 11, 2003
Appl. No.:

10/412104
Inventors:

William Van Osdol - Mountain View CA, US
Robert Gale - Los Altos CA, US
David Brandwein - New Brighton MN, US
Rama Padmanabhan - Los Altos CA, US
Joan Sunram - Coon Rapids MN, US
International Classification:

A61K009/70
A61K031/155
US Classification:

424/449000, 514/634000
Abstract:

Composition of matter for application to a body surface or membrane to administer a N-(2,5-Disubstituted phenyl)-N′-(3-substituted phenyl)-N′-methyl guanidine by permeation through the body surface or membrane, the composition comprising the guanidine compound to be administered, at a therapeutically effective rate, optionally in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of a guanidine for the prevention of neuropathic pain, neuropsychological deficits resulting from cardiac surgery (CABG), and other neurological disorders.

Transdermal Administration Of N-(2,5-Disubstituted Phenyl)-N'-(3-Substituted Phenyl)-N'-Methyl Guanidines
view source
US Patent:

20040258742, Dec 23, 2004
Filed:

Jul 20, 2004
Appl. No.:

10/895788
Inventors:

William Van Osdol - Mountain View CA, US
Robert Gale - Los Altos CA, US
David Brandwein - New Brighton MN, US
Rama Padmanabhan - Los Altos CA, US
Joan Sunram - Coon Rapids MN, US
International Classification:

A61K009/70
A61L015/16
US Classification:

424/449000
Abstract:

Composition of matter for application to a body surface or membrane to administer a N-(2,5-Disubstituted phenyl)-N′-(3-substituted phenyl)-N′-methyl guanidine by permeation through the body surface or membrane, the composition comprising the guanidine compound to be administered, at a therapeutically effective rate, optionally in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of a guanidine for the prevention of neuropathic pain, neuropsychological deficits resulting from cardiac surgery (CABG), and other neurological disorders.

System And Method For Tool Feedback Sensing
view source
US Patent:

20080208146, Aug 28, 2008
Filed:

Apr 7, 2006
Appl. No.:

11/910173
Inventors:

David H. Brandwein - New Brighton MN, US
Franklyn L. Frderickson - White Bear Lake MN, US
Karl M. Kropp - Saint Paul MN, US
International Classification:

A61M 5/158
US Classification:

604272
Abstract:

A microneedle application device for moving a microneedle array toward a target skin location includes a feedback sensor. The feedback sensor is operably connected to the microneedle application device, and is capable of generating an output corresponding to forces between the target skin location and the microneedle application device.